Thrombosis is considered to be closely related to several diseases such as atherosclerosis,
ischemic heart disease and stroke, as well as rheumatoid arthritis, hyperuricemia, and …

The aim of our article is to provide a concise review for clinicians entailing the main studies
that evaluated the efficacy and safety of target-specific oral anticoagulants (TSOAs) for …

We report 2 cases of apixaban use as prophylaxis against thromboembolism in the
nephrotic syndrome (NS), and review the existing literature on direct-acting oral …

Introduction: Theoretically, acupuncture in anticoagulated patients could increase bleeding
risk. However, precise estimates of bleeding complication rates from acupuncture in …

Rivaroxaban is a direct oral anti-factor Xa anticoagulant. It has recently been suggested that
rivaroxaban may affect platelet function in vitro; however, little is known about the clinical …

Historically, oral anticoagulation involved the administration of vitamin K antagonists, such
as warfarin. However, because of the need for frequent monitoring and the desire for safer …

Background: Despite the introduction of direct oral anticoagulants, the search for new oral
anticoagulants remains an urgent task. Objective: By using docking and scoring, based on …

A 78-year-old man developed back pain without fever and headache. On admission, he
showed pronounced positive Lasegue test without focal abnormalities. Due to atrial …

静脉血栓栓塞症的发病率是100/10 万~ 200/10 万, 是继心肌梗死和卒中后,
造成血管疾病相关死亡的第3 大原因[1]. 目前的标准治疗为迅速采取肠外抗凝5~ 7d …

Despite advances in interventional and pharmacologic therapy, survivors of myocardial
infarction remain at an increased risk of subsequent cardiovascular events. Initial …